HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

motexafin lutetium (Lutrin)

structure given in first source
Also Known As:
Lutrin; lutetium texaphyrin; Lu-Tex; Optrin; PCI 0123; PCI-0123; lutex
Networked: 28 relevant articles (0 outcomes, 7 trials/studies)

Bio-Agent Context: Research Results

Experts

1. Busch, Theresa M: 6 articles (09/2010 - 03/2002)
2. Zhu, Timothy C: 6 articles (08/2008 - 01/2002)
3. Hahn, Stephen M: 5 articles (08/2008 - 01/2002)
4. Woodburn, K W: 4 articles (06/2001 - 03/2000)
5. Wang, Hsing-Wen: 3 articles (09/2010 - 03/2002)
6. Yodh, A G: 3 articles (10/2006 - 03/2002)
7. Hayase, M: 3 articles (06/2001 - 11/2000)
8. Yu, Guoqiang: 2 articles (09/2010 - 09/2006)
9. Finlay, Jarod: 2 articles (08/2008 - 01/2006)
10. Mick, Rosemarie: 2 articles (08/2008 - 01/2006)

Related Diseases

1. Atherosclerosis
2. Prostatic Neoplasms (Prostate Cancer)
3. Macular Degeneration (Age-Related Maculopathy)
4. Coronary Artery Disease (Coronary Atherosclerosis)
5. Breast Neoplasms (Breast Cancer)

Related Drugs and Biologics

1. motexafin lutetium (Lutrin)
2. 1-phenyl-3,3-dimethyltriazene (PDT)
3. antrin
4. Oxygen
5. Singlet Oxygen
6. Prostate-Specific Antigen (Semenogelase)
7. Dihematoporphyrin Ether (Porfimer Sodium)
8. Retinaldehyde (Retinal)
9. Aluminum
10. verteporfin (Visudyne)

Related Therapies and Procedures

1. Photochemotherapy (Photodynamic Therapy)
2. Transplants (Transplant)
3. Stents
4. Phototherapy (Light Therapy)
5. Lasers (Laser)